Targeted metabolomics revealed distinct metabolic signatures in skin and BRafV600E driven melanoma tissues, showing notable changes such as increased levels of serotonin, SAG, 2-AG, and ARA, alongside decreased levels of NAEs. The gene discussed is SAG; the disease is melanoma.